Placebo powder
Placebo powder has been studied in 1 paper since 2025: 1 trial in people. The newest paper, Mar 29, 2025: “Effects of Blueberry Consumption on Fecal Microbiome Composition and Circulating Metabolites, Lipids, and Lipoproteins in a Randomized Controlled Trial of Older Adults with Overweight or Obesity: The BEACTIVE Trial”.
1 paper studies it1 findingUpdated
See all 1 papers on placebo powder
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“The placebo group exhibited significant reductions in total cholesterol, LDL-C, non-HDL-C, total LDL-P, large LDL-P, and ApoB”
- 1 lab in 1 country
- Funder: U.S. Highbush Blueberry Council
- 1 of 1 finding with company ties
- Human trial1
Studies in people
1 study gave placebo powder to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases LDL-C | Randomized trial12 weeks | 19 peopleBoth>60 yearsOlder adults; within placebo group, baseline vs 12 weeks | Nutrients, Mar 29, 2025 |
What did studies of placebo powder find?
1Studies of placebo powder measured one outcome, LDL-C.
LDL-C
downin humans1
1 study
LDL-C
downin humans1
Placebo powder decreases LDL-C in humans within placebo group, baseline vs 12 weeks.
“The placebo group exhibited significant reductions in total cholesterol, LDL-C, non-HDL-C, total LDL-P, large LDL-P, and ApoB”
Human trialwithin placebo group, baseline vs 12 weeks12 weeksn = 19
Nutrients